University of Arkansas initiates PTSD therapy study for pregnant women in substance use care

For a pharmaceutical company, the University of Arkansas's study on Written Exposure Therapy (WET) via tele-health for pregnant and postpartum women with PTSD presents several strategic considerations.

The initiation of this study by the University of Arkansas is significant as it explores a novel tele-health approach to treat PTSD in a vulnerable population—pregnant and postpartum women in substance misuse care. This trial could redefine treatment protocols and acceptance of tele-health solutions in mental health, particularly for those facing dual challenges of PTSD and substance use.

Humanexa recommends Monitor: Monitoring is advisable as the study progresses to capture enrollment rates and participant feedback, which will provide insights into the feasibility and acceptability of tele-health interventions for PTSD. This information could be critical for adapting clinical strategies and aligning with emerging treatment standards in mental health care.

Monitor enrollment rates, interim results, and feedback from participants regarding the acceptability of the therapy.